Karyopharm Therapeutics said it is on track to file an application this month seeking U.S. Food and Drug Administration (FDA) accelerated approval of its oral therapy selinexor, when combined with Jakafi (ruxolitinib), for adults…

We each get our inspiration from our own (sometimes) fleeting moments. Tonight, I listened to a brilliant live concert by world-class musician friends. And the beauty of it? I didn’t even have to be there.

Damora Therapeutics has launched a global Phase 1/1b clinical trial testing DMR-001, an experimental antibody therapy, in adults with myelofibrosis driven by CALR gene mutations. DMR-001 specifically targets…